Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4414182)

Published in Oncotarget on February 28, 2015

Authors

Martin Wartenberg1,2, Inti Zlobec2, Aurel Perren1,2, Viktor Hendrik Koelzer1,2, Beat Gloor3, Alessandro Lugli1,2, Eva Karamitopoulou1,2

Author Affiliations

1: Clinical Pathology Division, University of Bern, Bern, CH-3010, Switzerland.
2: Translational Research Unit, Institute of Pathology, University of Bern, Bern, CH-3010, Switzerland.
3: Department of Visceral Surgery, Insel University Hospital, Bern, CH-3010, Switzerland.

Articles cited by this

Hallmarks of cancer: the next generation. Cell (2011) 140.01

Cancer-related inflammation. Nature (2008) 34.21

Immunity, inflammation, and cancer. Cell (2010) 28.27

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96

Pancreatic cancer. N Engl J Med (2010) 13.88

Alternative activation of macrophages: mechanism and functions. Immunity (2010) 12.43

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A (2005) 10.89

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol (2010) 9.59

The immunobiology of cancer immunosurveillance and immunoediting. Immunity (2004) 9.39

Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38

Pancreatic cancer. Annu Rev Pathol (2008) 6.96

Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol (2010) 6.85

Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res (2006) 6.52

Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest (2007) 6.31

The central role of CD4(+) T cells in the antitumor immune response. J Exp Med (1998) 6.02

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol (2007) 5.28

The pancreas cancer microenvironment. Clin Cancer Res (2012) 4.10

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One (2009) 3.86

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res (2006) 3.38

Differential macrophage programming in the tumor microenvironment. Trends Immunol (2012) 3.18

Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res (2009) 2.61

Inflammation and prognosis in colorectal cancer. Eur J Cancer (2005) 2.47

Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Eur J Cancer (2012) 2.46

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res (2007) 2.21

Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer (2013) 1.96

Tumour budding in colorectal carcinoma. Histopathology (2007) 1.93

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget (2010) 1.88

Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst (2013) 1.85

Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur J Immunol (2011) 1.55

Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer (2012) 1.39

Dual roles for immunity in gastrointestinal cancers. J Clin Oncol (2010) 1.31

CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology (2010) 1.26

Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head. Cancer Sci (2012) 1.25

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer. Br J Cancer (2009) 1.21

Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol (2008) 1.19

Adjusting for multiple testing in studies is less important than other concerns. BMJ (1999) 1.15

M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas (2013) 1.09

Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers. Histopathology (2010) 1.05

Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction. FEBS Lett (2006) 0.97

Non-canonical alternatives: what a macrophage is 4. J Exp Med (2012) 0.95

Pancreas cancer on the rise: are we up to the challenge? J Natl Cancer Inst (2013) 0.81